By Tess Stynes Kohlberg Kravis Roberts & Co. agreed to acquire Pfizer (NYSE:PFE) Like many large pharmaceutical companies, Pfizer is facing generic competition on some of its biggest-selling drugs in coming years and has been adjusting its strategy...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer Sells Capsugel Unit for $2.4 Billion
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account